Lung Cancer Associated with Seronegative Myasthenia Gravis

被引:5
作者
Niimi, Kyoko [1 ]
Nagata, Eiichiro [2 ]
Murata, Naoko [1 ]
Sato, Masako [1 ]
Tanaka, Jun [1 ]
Horio, Yukihiro [1 ]
Takiguchi, Hiroto [1 ]
Tomomatsu, Hiromi [1 ]
Tomomatsu, Katsuyoshi [1 ]
Hayama, Naoki [1 ]
Oguma, Tsuyoshi [1 ]
Aoki, Takuya [1 ]
Urano, Tetsuya [1 ]
Abe, Tadashi [1 ]
Inomoto, Chie [3 ]
Takizawa, Shunya [2 ]
Asano, Koichiro [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa 25912, Japan
[2] Tokai Univ, Sch Med, Dept Neurol, Hiratsuka, Kanagawa 25912, Japan
[3] Tokai Univ, Sch Med, Dept Pathol, Hiratsuka, Kanagawa 25912, Japan
关键词
lung cancer; seronegative myasthenia gravis; paraneoplastic syndrome; EPITHELIAL-CELLS; AUTOANTIBODIES; MALIGNANCY; CARCINOMA;
D O I
10.2169/internalmedicine.54.3363
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 64-year-old man presented with diplopia, muscle weakness, a pulmonary nodule and mediastinal widening on a chest radiograph. He was diagnosed with clinical stage IIIA (T2aN2M0) lung cancer. His neurological symptoms worsened following the initiation of thoracic radiation therapy (60 Gy) and chemotherapy. A diagnosis of myasthenia gravis (MG) was confirmed with a repetitive nerve stimulation test that showed a waning pattern, and a positive edrophonium test, although neither anti-acetylcholine receptor antibodies nor anti-muscle-specific tyrosine kinase antibodies were detected. The ptosis and limb muscle weakness improved with prednisolone and acetylcholinesterase inhibitor treatment, and a partial response of the lung cancer to chemoradiotherapy was obtained. However, the ptosis and limb muscle weakness worsened again following a recurrence of the lung cancer. The herein described case, in which lung cancer and MG occurred and recurred simultaneously, suggests that MG can develop as a paraneoplastic syndrome of lung cancer.
引用
收藏
页码:1381 / 1384
页数:4
相关论文
共 23 条
[1]   MYASTHENIA-GRAVIS ASSOCIATED WITH SMALL-CELL CARCINOMA OF THE LUNG [J].
FUJITA, J ;
YAMADORI, I ;
YAMAJI, Y ;
YAMAGISHI, Y ;
TAKIGAWA, K ;
TAKAHARA, J .
CHEST, 1994, 105 (02) :624-625
[2]   ANTIGEN PRESENTATION BY THYMOMA EPITHELIAL-CELLS FROM MYASTHENIA-GRAVIS PATIENTS TO POTENTIALLY PATHOGENIC T-CELLS [J].
GILHUS, NE ;
WILLCOX, N ;
HARCOURT, G ;
NAGVEKAR, N ;
BEESON, D ;
VINCENT, A ;
NEWSOMDAVIS, J .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 56 (01) :65-76
[3]  
Hazard P B, 1986, J Tenn Med Assoc, V79, P273
[4]   Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Myasthenia Gravis [J].
Higuchi, Osamu ;
Hamuro, Johko ;
Motomura, Masakatsu ;
Yamanashi, Yuji .
ANNALS OF NEUROLOGY, 2011, 69 (02) :418-422
[5]   Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies [J].
Hoch, W ;
McConville, J ;
Helms, S ;
Newsom-Davis, J ;
Melms, A ;
Vincent, A .
NATURE MEDICINE, 2001, 7 (03) :365-368
[6]  
Kataoka K., 2009, JPN J LUNG CANC, V49, P273
[7]   Myasthenia gravis with a paraneoplastic marker [J].
Leavitt, JA .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2000, 20 (02) :102-105
[8]   Extrathymic malignancies in patients with myasthenia gravis [J].
Levin, N ;
Abramsky, O ;
Lossos, A ;
Karussis, D ;
Siegal, T ;
Argov, Z ;
Ben Hur, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 237 (1-2) :39-43
[9]   Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors [J].
Maus, ADJ ;
Pereira, EFR ;
Karachunski, PI ;
Horton, RM ;
Navaneetham, D ;
Macklin, K ;
Cortes, WS ;
Albuquerque, EX ;
Conti-Fine, BM .
MOLECULAR PHARMACOLOGY, 1998, 54 (05) :779-788
[10]   NICOTINIC NEURONAL ACETYLCHOLINE-RECEPTOR ALPHA-3 SUBUNIT TRANSCRIPTION IN NORMAL AND MYASTHENIC THYMUS [J].
MIHOVILOVIC, M ;
HULETTE, C ;
MITTELSTAEDT, J ;
AUSTIN, C ;
ROSES, AD .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 681 :83-96